5G network pivotal in healthcare transformation: Ericsson Healthcare to Homecare Report Ruby Khatun Khatun6 Jun 2017 12:21 PM ISTNext-generation networks will be pivotal in healthcare transformation, providing transmission efficiency in an ecosystem of feedback and alerts,...
Cadila Healthcare gets EIR from USFDA for Baddi facility Ruby Khatun Khatun6 Jun 2017 12:14 PM ISTNew Delhi: Drug firm Cadila Healthcare has received Establishment Inspection Report (EIR) from the US health regulator for its Baddi facility in...
Zydus Cadila gets USFDA nod for anti-depressant Ruby Khatun Khatun6 Jun 2017 12:12 PM ISTNew Delhi: Drug firm Zydus Cadila has received the US health regulator’s nod to market Mirtazapine orally disintegrating tablets, an anti-depressant,...
Bristol-Myers Squibb Announces New Collaboration to Evaluate Combination Therapy in Colorectal Cancer Ruby Khatun Khatun6 Jun 2017 12:12 PM ISTNEW YORK: Bristol-Myers Squibb Company announced it has entered into a clinical research collaboration with Novartis to investigate the safety,...
Bharat Biotech's chikungunya vaccine enters clinical trials Ruby Khatun Khatun6 Jun 2017 12:12 PM ISTHyderabad: Bharat Biotech said that the phase 1 human clinical trials of the indigenously developed chikungunya (CHIKV) vaccine is underway in India...
Roche combo of breast cancer drugs shows modest benefit Ruby Khatun Khatun6 Jun 2017 12:12 PM ISTCHICAGO: A clinical trial from Roche Holding AG combining the company's newer targeted drug for breast cancer with an older treatment resulted in a...
Natco Pharma plans to launch 8-10 branded formulations this year Ruby Khatun Khatun5 Jun 2017 3:21 PM ISTNew Delhi: Natco Pharma plans to launch around 8-10 new products in domestic branded formulations segment during the current year as it aims to grow...
Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration Ruby Khatun Khatun5 Jun 2017 3:20 PM ISTBOULDER: Array BioPharma and Bristol-Myers Squibb Company announced the companies have entered into a clinical research collaboration to investigate...
Pfizer shares trim most of early gains, end 3 Percent Higher Ruby Khatun Khatun5 Jun 2017 3:17 PM ISTNew Delhi: Shares of drug firm Pfizer trimmed most of its early gains and ended 3 per cent higher on emergence of profit-booking.The stock which...
Early use of Johnson & Johnson's Zytiga extends prostate cancer survival Ruby Khatun Khatun5 Jun 2017 3:15 PM ISTCHICAGO: Adding Johnson & Johnson's Zytiga to standard hormone therapy reduced by nearly 40 percent the chance of death for men newly diagnosed...
FDA Approves New Novo Nordisk Treatment for Patients with Hemophilia Ruby Khatun Khatun5 Jun 2017 3:14 PM ISTPLAINSBORO: Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application for REBINYN®...
Drug regulator meets pharma sector bodies on GST and supply Ruby Khatun Khatun5 Jun 2017 3:11 PM ISTNEW DELHI: National drug pricing regulator National Pharmaceutical Pricing Authority (NPPA) has said it has held meetings with pharma sector...
